Welcome to our dedicated page for Huntington Bancshares SEC filings (Ticker: HBAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. SEC filings for Huntington Bancshares Incorporated (Nasdaq: HBAN), a regional bank holding company headquartered in Columbus, Ohio. Through these documents, investors can review how Huntington reports material events, merger agreements, dividend declarations, and other regulatory information related to its banking, payments, wealth management, and risk management activities.
Huntington frequently uses Form 8‑K to disclose significant developments. Recent 8‑K filings describe the Agreement and Plan of Merger among Huntington, The Huntington National Bank, and Cadence Bank, under which Cadence will merge with and into The Huntington National Bank. Subsequent 8‑Ks and exhibits document regulatory approvals from the Office of the Comptroller of the Currency, shareholder approvals, and the expected closing timing, as well as cautionary language regarding forward‑looking statements. Other 8‑Ks outline regulatory approvals and closing expectations for the merger of Veritex Holdings, Inc. and its bank subsidiary into Huntington and The Huntington National Bank.
Filings also cover capital and dividend actions. For example, Huntington has filed 8‑Ks announcing quarterly cash dividends on its common stock and on multiple series of preferred stock, including the 5.70% Series I Non‑Cumulative Perpetual Preferred Stock represented by depositary shares trading under HBANM. These reports specify dividend amounts, record dates, and payment dates. Additional 8‑Ks furnish investor presentations and earnings materials, such as quarterly financial supplements and conference slide decks.
On Stock Titan, users can view these HBAN filings as they are made available from EDGAR and use AI‑powered summaries to understand the key points in lengthy documents, including merger terms, risk factor discussions, and details about Huntington’s listed securities. This helps investors quickly interpret complex regulatory text while retaining the ability to read the complete original filings.
Jeffrey L. Tate, a director of Huntington Bancshares Inc. (HBAN), reported acquisitions on 10/01/2025 under a director deferred compensation arrangement. The filing shows 461.241 shares of common stock acquired at a stated price of $0.0000, increasing his direct holdings to 112,657.268 shares. An additional 45.238 shares were recorded as indirect holdings, bringing that total to 5,063.708 shares. The Form 4 includes an Exhibit 24 power of attorney and was signed by an attorney-in-fact on 10/03/2025.
Stephen D. Steinour, who is listed as President, CEO & Chairman and a Director of Huntington Bancshares Inc. (HBAN), filed a Form 4 disclosing non-derivative stock transactions dated 10/01/2025. The filing reports two acquisitions of common stock on that date: 6,326.503 shares and 491.145 shares, each recorded with a price of $0.0000. Following the reported transactions the document lists a total direct beneficial holding of 1,872,763.404 shares and various indirect holdings allocated to plans and trusts, including 3,441,119.559, 2,898,505, 496,500, 90,363.268, and other smaller allocations as shown in the filing. The Form 4 includes an exhibit index reference to a substitute power of attorney and is signed by an attorney-in-fact on 10/03/2025.
Brantley J. Standridge, identified as Senior Exec. V.P. of Huntington Bancshares Inc. (HBAN), reported an acquisition of 2,376.67 shares of Common Stock on 10/01/2025 via a Form 4. The reported transaction lists a price of $0.0000 and shows 331,168.429 shares beneficially owned following the transaction. The filing includes an Exhibit 24 substitute power of attorney and was signed on behalf of the reporting person by Rachel L. Lawless, Attorney-in-Fact on 10/03/2025.
Roger J. Sit, a director of HUNTINGTON BANCSHARES INC /MD/ (HBAN), reported purchases on 10/01/2025. The Form 4 shows a direct acquisition of 1,514.358 shares (transaction code A) at a reported price of $0.0000, leaving 193,110.333 shares held directly after the transaction. The filing also reports an indirect acquisition of 357.324 shares, bringing indirect holdings to 39,997.025 shares via several vehicles: 22,921 shares in the Director Deferred Compensation Plan, 152,572 shares by the Richard A. Sit Trust, 4,713 shares by a trust, and 152,572 noted for Sit Investment Associates.
The filing includes an exhibit: Exhibit 24 (Substitute Power of Attorney), and is signed by Rachel L. Lawless, Attorney-in-Fact on 10/03/2025. The filer clarifies the statement is not an admission of beneficial ownership for Section 16 purposes.
Huntington Bancshares (HBAN) director Teresa H. Shea reported acquisitions on a Form 4 dated 10/01/2025. The filing shows an acquisition of 182.758 shares of Common Stock directly and 50.96 shares indirectly under the Director Deferred Compensation Plan, for a combined 233.718 shares. The reported price for both entries is $0.0000, and the holdings after the transactions are 21,274.515 shares held directly and 5,704.219 shares held indirectly. The filer is identified as a Director, and the Form was filed by one reporting person.
Katherine M. A. Kline, a Director of Huntington Bancshares Inc. (HBAN), filed a Form 4 reporting transactions dated 10/01/2025. The filing reports the acquisition of 800.06 shares of common stock and an additional acquisition of 44.026 shares attributable to a director deferred compensation plan, both shown at a price of $0.0000. After the reported transactions, the filing lists 88,755.371 shares as directly beneficially owned and 4,927.986 shares as indirectly beneficially owned via the deferred compensation plan.
The Form 4 identifies the reporting persons address as Huntington Center, 41 S. High Street, Columbus, OH 43215 and includes an exhibit index reference to a substitute power of attorney. The filing contains the signature of an attorney-in-fact dated 10/03/2025. The statement clarifies that the filing is not an admission of beneficial ownership for Section 16 purposes.
David L. Porteous, a director of HUNTINGTON BANCSHARES INC /MD/ (HBAN), reported multiple acquisitions of common stock on 10/01/2025. The Form 4 shows acquisitions recorded as 1,268.493, 640.262, 140.739, and 1,062.201 shares under various accounts including an IRA, SEP-IRA, and a Director Deferred Compensation Plan, each with a reported price of $0.0000. The filing also lists 10,136.631 shares indicated as indirect ownership by spouse. The filer disclaims that the statement is not an admission of beneficial ownership. The form is signed by Rachel L. Lawless as attorney-in-fact on 10/03/2025.
Sarah E. Pohmer, SEVP-CHRO of Huntington Bancshares Inc. (HBAN), reported an insider purchase on 10/01/2025. The filing shows acquisition of 1,114.393 shares of common stock at a price of $0.0000 (indicating a grant or similar non‑cash issuance). After the transaction she beneficially owns 153,205.126 shares. The Form 4 was signed by attorney‑in‑fact Rachel L. Lawless on 10/03/2025.
Scott D. Kleinman, identified as Senior Exec. V.P. and an officer of HUNTINGTON BANCSHARES INC (HBAN), reported insider transactions on 10/01/2025 via Form 4. The filing shows two non-derivative common stock entries: an acquisition of 2,061.875 shares at a reported price of $0.0000, leaving 452,894.989 shares beneficially owned following the transaction as a direct holding. A separate acquisition of 3.177 shares at $0.0000 is reported as an indirect holding of 355.88 shares attributable to the issuer's Supplemental Stock Purchase and Tax Savings Plan.
The filing includes an exhibit reference to a substitute power of attorney and is signed by Rachel L. Lawless, Attorney-in-Fact on 10/03/2025. The reporting person disclaims that the filing does not itself constitute admission of beneficial ownership under Section 16.
Kenneth J. Phelan, a director of HUNTINGTON BANCSHARES INC (HBAN), reported acquisitions of Common Stock on 10/01/2025. The Form 4 shows two non-derivative stock entries: 851.349 shares acquired (direct) and 483.095 shares acquired (indirect via the Director Deferred Compensation Plan), both at a reported price of $0.0000 for record purposes.
Following these transactions, the filing reports total beneficial ownership of 134,445.125 shares directly and 54,075.157 shares indirectly. The filing includes an exhibit (Exhibit 24) naming a substitute power of attorney and is signed by an attorney-in-fact on 10/03/2025.